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ABSTRACT: Abstract Word Count: 232 32 
Background: Exercise limitation is almost universal among Fontan patients.  Identifying unique 33 
clinical features in the small fraction of Fontan patients with normal exercise capacity (high 34 
capacity Fontan, HCF) provides potential to inform clinical strategies for those with low exercise 35 
capacity (usual Fontan, UF).  Methods: We performed a retrospective chart review of all single 36 
ventricle patients palliated with a Fontan operation who underwent incremental cardiopulmonary 37 
exercise testing at Cincinnati Children’s Hospital Medical Center from 2013-2018.  Comparison 38 
was between patients with peak oxygen uptake (VO2peak) < vs >80% predicted.  Results: 39 
Twenty two of 112 patients were classified as HCF (68% female; 18±7 years).  During 40 
incremental exercise, VO2peak (86.1±6.1% vs 62±12.2 % predicted; p<0.001) was greater in 41 
HCF vs UF despite similar chronotropic impairment, resulting in a greater oxygen pulse in HCF.  42 
Pulmonary function, breathing reserve and VE/VCO2 slope were not different between groups.  43 
HCF were more likely to self-report exercise >4 days/week for at least 30 minutes (77% vs 10%, 44 
p<0.001), have normal systolic function (95% vs 74%, p=0.003), have fewer post-operative 45 
complications (8% vs 36%, p=0.04) and shorter post-Fontan length of stay (8±2.8 vs 12.4±0.9 46 
days, p=0.04).  Conclusions: Approximately 1 in 5 Fontan patients who undergo 47 
cardiopulmonary exercise testing have normal exercise capacity despite chronotropic 48 
impairment.  This implies a better preserved stroke volume, perhaps due to greater muscle pump-49 
mediated preload.  Additionally, a complicated perioperative Fontan course is associated with 50 





Electronic Table of Contents Summary: 54 
Identifying unique features in Fontan patients with normal exercise capacity provides potential to 55 
inform clinical strategies for those in whom exercise capacity is limited.  Approximately 1 in 5 56 
Fontan patients have normal exercise capacity despite chronotropic impairment.  This implies a 57 
better preserved stroke volume, perhaps due to greater muscle pump-mediated preload.  58 
Pulmonary function and ventilatory responses during exercise did not differ.  Additionally, a 59 
complicated perioperative Fontan course is associated with eventual impaired functional 60 
capacity. 61 
 62 
INTRODUCTION:   63 
The Fontan operation provides excellent initial palliation for patients with univentricular 64 
circulations. Venous return from the body is surgically redirected into the pulmonary arteries 65 
without first passing into the single ventricle.  In the process, it relieves cyanosis and reduces 66 
volume load of the single ventricle (1).  Inherent to the hemodynamic characteristics of the 67 
Fontan procedure is a restriction in ventricular preload, especially during exercise, due to the 68 
lack of ventricular augmentation of pulmonary blood flow (2).  This results in a near universal 69 
limitation of aerobic capacity (VO2peak), with the majority of patients being below 80% 70 
predicted VO2peak (3,4).  Low aerobic capacity is an important marker of mortality and clinical 71 
morbidity in recent studies (5).  Nevertheless, a small fraction of Fontan patients have normal 72 
aerobic capacity on cardiopulmonary exercise testing (VO2peak > 80% predicted) (6).  Very little 73 
is known about this group.  Their clinical and physiological characteristics provide potential to 74 
better understand how more favorable hemodynamic responses may be harnessed in the 75 
4 
 
therapeutic setting.  We undertook this study to: [i] characterize the clinical phenotype of Fontan 76 
patients with normal exercise capacity; [ii] define differences in submaximal and maximal 77 
responses to incremental cardiopulmonary exercise testing between high capacity Fontan (HCF) 78 
and the usual Fontan (UF) population who manifest exercise limitation; and [iii] determine 79 
possible risk factors that can predict future impaired functional capacity, including how 80 
ventricular function affects exercise results in the UF group.   81 
METHODS:  82 
We performed a retrospective chart review of all single ventricle patients with Fontan 83 
palliation who underwent a cardiopulmonary exercise test (CPET) at Cincinnati Children’s 84 
Hospital Medical Center from 2013-2018.  HCF patients were defined on the basis of having 85 
normal VO2peak (i.e. >80% predicted), and were compared with UF patients with low VO2peak 86 
(i.e. <80% predicted) (7).  Exclusion criteria included lack of a maximal effort exercise test and 87 
incomplete exercise data.  Demographic data was obtained from chart review including age, sex, 88 
height, weight, medications, age at testing, age at Fontan, physical activity and New York Heart 89 
Association (NYHA) functional class.  Patients were determined to be physically active by self-90 
report of active engagement in organized sports, regular attendance at fitness classes or moderate 91 
to vigorous effort exercise ≥4 days a week for 30 minutes or more.  Additionally, systemic 92 
ventricular systolic function and atrioventricular valve insufficiency was recorded from the 93 
echocardiogram report performed within six months of the CPET and was measured by two 94 
independent pediatric cardiologists.  UF patients were further subdivide into having normal and 95 
abnormal ventricular systolic function to further examine the impact of ventricular function on 96 
the exercise responses in these more typical Fontan patients.  Laboratory results from annual 97 
screening labs were recorded, including hemoglobin, platelets, aspartate aminotransferase (AST), 98 
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alanine aminotransferase (ALT), total serum protein, serum albumin, and gamma-glutamyl 99 
transferase (GGT).  When available, Fontan surgical records and discharge summaries were 100 
reviewed and the pre-Fontan oxygen saturation, length of stay, time from Glenn to Fontan, total 101 
cardiopulmonary bypass time, weight and height and hospital discharge, and post-surgical 102 
complications (including complicated effusions, acquired heart block requiring pacemaker 103 
placement, wound infection, surgical revision, catheter based intervention prior to discharge 104 
and/or pancreatitis) were recorded. 105 
All patients underwent exercise testing on a stationary cycle ergometer (Lode Corival) 106 
using an incremental ramp protocol.  The incremental rate was chosen based on the patient’s 107 
body surface area (BSA) with a goal to reach intolerance in approximately 10 minutes. 108 
Cardiopulmonary responses to exercise were assessed breath-by-breath (Ultima CardiO2, MGC 109 
Diagnostics).  Criteria for a maximal effort exercise test was if 2 of the following 3 criteria were 110 
met: respiratory exchange ratio (RER) >1.10; maximal heart rate greater >85% of the age 111 
predicted maximum (220 - age in years); or maximal Rating of Perceived Exertion >18 on a 6-20 112 
scale (8).  Predicted VO2peak was calculated per Wasserman et al and Cooper et al (7, 9).  In 113 
patients with a body mass index (BMI) < 18 and > 25, the underweight and overweight 114 
regression equations were used (7).  Percent predicted peak power (in watts, W) was calculated 115 
using the prediction equation described by Wasserman et al (7).  The chronotropic index (CI) 116 
was defined as the heart rate reserve (measured peak heart rate minus resting heart rate) divided 117 
by the difference between the predicted peak heart rate and the resting heart rate multiplied by 118 
100; a CI >80% was identified as normal (10).   119 
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The anaerobic threshold (AT) was determined non-invasively using the modified V-slope 120 
method (11).  Physiologic variables during submaximal exercise were then measured at 25% 121 
peak power and AT.  25% peak power was below AT for all participants.  122 
As part of the exercise test, all patients underwent pulmonary function testing (PFT) 123 
using a metabolic cart (TrueMax 2400; Parvo Medics or Ultima CardiO2; Medgraphics).  Each 124 
patient performed three tests with the best result used for analysis.  Predicted FVC and FEV1 125 
were based on gender, age and height (12).  Maximal voluntary ventilation (MVV) was 126 
calculated from FEV1 x 40 (13).  Breathing reserve was defined as follows: (MVV - maximum 127 
exercise ventilation)/MVV x 100 (7).  Additionally, oxygen saturation by pulse oximetry (SpO2) 128 
at rest and peak exercise were recorded from a forehead probe (Radical 7, Masimo). 129 
Data are presented as mean ± standard deviation.  Differences between HCF and UF 130 
groups various states of exercise were assessed using an unpaired t-test for normally distributed 131 
data and the Wilcoxon Signed-Rank Test for non-normally distributed data where appropriate.  132 
Univariate association between normally distributed variables was estimated using the Pearson 133 
correlation coefficient.  A stepwise multivariable linear regression modeling procedure with 0.1 134 
as the significance level for entry and 0.05 as the significance level for retention in the model 135 
was constructed to determine independent predictors of percent predicted VO2peak.  In addition, 136 
differences between UF patients with normal and abnormal systolic function as measured by 137 
echocardiogram were assessed using an unpaired t-test for normally distributed data and the 138 
Wilcoxon Signed-Rank Test for non-normally distributed data where appropriate.  All p-values 139 
were two-tailed (where applicable) and differences and associations were considered significant 140 
when p鳥<鳥0.05.  Statistical analyses were performed using JMP®, Version 14 from SAS Institute 141 
Inc. (Cary, NC). 142 
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RESULTS:  143 
A total of 130 Fontan patients underwent cardiopulmonary exercise testing from 2013-144 
2018 with 112 completing a maximal effort test and included for analysis.  A total of 22 patients 145 
achieving a VO2peak >80% of predicted.  These 22 patients comprised the HCF group.  Baseline 146 
characteristics are shown (Table 1).  HCF tended (p=0.06) to be more predominantly female than 147 
the UF group.  148 
The HCF group comprised of the following anatomic diagnoses: tricuspid atresia (n=12, 149 
54%), hypoplastic left heart syndrome (n=3, 14%), double inlet left ventricle (n=4, 18%), 150 
pulmonary atresia with intact ventricular septum (n=2, 9%), and double outlet right ventricle 151 
with pulmonary atresia (n=1, 5%).  This distribution was not significantly different from the UF 152 
group: tricuspid atresia (n=35, 39%), hypoplastic left heart syndrome (n=29, 32%), double inlet 153 
left ventricle (n=11, 12%), pulmonary atresia with intact ventricular septum (n=7, 8%), double 154 
outlet right ventricle with pulmonary atresia (n=4, 5%), transposition of the great arteries with 155 
pulmonary stenosis (n=1, 2%), and unbalanced complete atrioventricular defect (n=1, 2%) 156 
(Table 1).  The type of Fontan connection in the HCF group included extracardiac conduit (n=12, 157 
54%), lateral tunnel (n=8, 36%), classic atriopulmonary connection (n=1, 5%) and unknown 158 
(n=1, 5%) (Table 1).  Fontan surgical records and detailed discharge summaries following 159 
Fontan completion were available for 80 patients (73%).  The HCF group had a shorter length of 160 
stay (8±2.8 vs 12.4±0.9 days, p=0.04), lower body mass index at hospital discharge (14.5±1.3 vs 161 
15.9±2.1 kg/m2, p=0.01) and fewer post-operative complications following the Fontan (8% vs 162 
36%, p=0.04) than the UF group (Table 2).   163 
Laboratory findings near the time of the CPET were not significantly different between 164 
groups (Table 2).  Four (18%) HCF patients had evidence of Fontan associated liver disease as 165 
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they had splenomegaly, thrombocytopenia and hepatic nodules on imaging as opposed to 33 166 
(37%) of UF (p=0.08).  There was one patient death and one listed for transplant during the study 167 
period, both in the UF group.  In the HCF group, 1 patient had a pacemaker/ICD compared to 6 168 
patients in the UF group. 169 
In this cohort, 102 patients had an echocardiogram at the time of their CPET (Table 2).  170 
Among HCF, only 1/21 (4.5%) had had ventricular systolic dysfunction classified as mild or 171 
greater, as opposed to 21/81 (26.0%) in the UF group (p=0.03).  There was no significant 172 
difference between the degree of systemic atrioventricular valve regurgitation between the 173 
groups.  Pulmonary function data were available (i.e. good effort given during the test and 174 
complete data available) for 95 patients (19 HCF, 76 UF), and there were no significant 175 
differences between HCF and UF in the measures evaluated (Table 2).  HCF patients tended to 176 
have a lower VE/VCO2 slope (32.1±4.4 vs 34.9±7.3, p=0.1).  17 of the 22 HCF patients self-177 
reported their functional capacity as active including regular performance of running, weight 178 
lifting, cycling, dance or swimming as opposed to 9 of the 88 UF patients (p<0.00001).  There 179 
was no significant difference in the NYHA functional class between groups. 180 
 At 25% peak power HCF patients had lower heart rate (47.4±6.9 vs 50.9±6.6 % 181 
predicted, p=0.03), yet greater VO2 (34.3±10.5 vs 26.7±6 % predicted VO2peak, p<0.0001).  182 
Heart rate at AT was not different between HCF and UF, yet % predicted VO2peak remained 183 
substantially higher in the HCF group (Table 3; Figure 1).  At peak exercise, there remained only 184 
a significant difference between the groups in % predicted VO2peak (Figure 2), which resulted in 185 
a normal to above normal O2Pulse in the HCF group compared to a low O2Pulse in the UF group 186 
(Table 4).  To determine whether differences at 25% peak power were associated with the greater 187 
absolute power achieved in HCF patients, we evaluated responses at the same absolute power in 188 
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both groups (40 W).  Four UF patients were removed from this analysis because 40W was above 189 
AT.  In HCF at 40 W, VO2 (39.9±12.2 vs 32.4±10.4 % predicted VO2peak, p=0.004) remained 190 
significantly greater, without a significant difference in HR (52.1±9 vs 54.2±8 % predicted, 191 
p=0.29).  192 
 We also compared normal (n=60) and abnormal (n=21) ventricular systolic function on 193 
echocardiogram within the UF group.  At 25% peak power, there was no significant difference in 194 
the VO2, heart rate or O2Pulse between UF with normal vs abnormal systolic function.  At AT, 195 
heart rate was significantly greater in UF with normal vs abnormal systolic function (67.7±11 vs 196 
61.7±11.3 % predicted, p=0.04) (Figure 3).  This difference was maintained at peak exercise 197 
(84.3±9.2 vs 73.3±15.6 % predicted, p<0.005).  VO2peak was also less in UF with systolic 198 
dysfunction (63.7±11 vs 56±14.3 % predicted, p=0.02) (Figure 3).    199 
On univariate analysis, echocardiographic ventricular systolic function at time of CPET, 200 
a self-reported active lifestyle, length of stay following Fontan completion, and post-operative 201 
complications were associated with % predicted VO2peak (Table 5).  On multivariable analysis, 202 
a self-reported active lifestyle and ventricular systolic function at time of CPET were associated 203 
with % predicted VO2peak (Table 5).  204 
DISCUSSION:  205 
Functional capacity, as assessed by exercise testing, is usually severely limited in Fontan 206 
patients. The physiological mechanisms of this limitation includes inadequate preload 207 
augmentation to the single ventricle (14), inadequate heart rate reserve (15), and poor 208 
conditioning with relative skeletal muscle weakness (16).  Poor exercise performance is 209 
associated with acute cardiovascular decompensation, need for heart transplantation, and early 210 
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mortality (17).  There is evidence however that a few Fontan patients achieve normal exercise 211 
performance (6).  The most notable study looking at high-performing Fontan patients involved 212 
14 patients all of which had > 80% predicted peak VO2 on CPET and without comparison to 213 
Fontan patients with poor exercise capacity (6).  Their characteristics however remain poorly 214 
understood despite the obvious potential lessons that can be learned from their exercise 215 
responses. 216 
This study examined the exercise adaptation of high capacity Fontan patients during ramp 217 
incremental cycle ergometer exercise up to the limit of tolerance. We found that 1 in 5 Fontan 218 
patients who undergo cardiopulmonary exercise testing have normal exercise capacity for their 219 
age, gender, and body habitus.  Such high functioning Fontan patients tend to lead physically 220 
more active lifestyles, but do not differ in baseline spirometry or the ventilatory response to 221 
exercise.  While there was a statistically significant difference between the groups in baseline 222 
SpO2 prior to CPET, this is likely not clinically significant as both groups were normal. 223 
We did not find any significant difference in body habitus, gender, systemic right vs. left 224 
ventricle, or NYHA functional class between HCF and UF patients.  Instead, profound 225 
differences were demonstrated in gas exchange patterns at submaximal and peak exercise.  In 226 
HCF, VO2 was greater from early to peak exercise, with no difference between groups in the 227 
degree of mild chronotropic impairment. This resulted in a greater O2Pulse in HCF throughout 228 
exercise by allowing more time for ventricular filling at slower heart rates as expected based on 229 
the Starling mechanism.  This is somewhat expected when making a comparison between fit and 230 
less fit individuals.  This O2Pulse pattern implies greater stroke volume augmentation and/or 231 
peripheral O2 extraction in the fit Fontan phenotype.  However, greater stroke volume is the 232 
more likely mechanism given that fractional O2 extraction is relatively invariant among patients 233 
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when normalized to % VO2peak (7) or in total cavopulmonary connection circulations (19).  In 234 
circulations with a subpulmonary pump, exercise adaptation is facilitated through the effect of 235 
the muscle and respiratory pumps augmenting ventricular preload (18).  In patients with a Fontan 236 
circulation, stroke volume, chronotropy and cardiac augmentation is blunted throughout exercise, 237 
beginning at unloaded exercise.  We could not demonstrate differences in ventilatory responses 238 
or ventilatory efficiency, emphasizing the potential role of the skeletal muscle pump (particularly 239 
lower limb muscle mass and strength) in enhancing the exercise response in the HCF group. In 240 
addition, the workload during different stages of exercise closely mirrored the oxygen 241 
consumption, as expected in comparing fit and less fit individuals.   242 
Shafer et al. demonstrated early blunting of SV augmentation in Fontan patients, but 243 
showed that cardiac output can still be increased through the greater heart rate response and 244 
increased preload achieved through the skeletal and respiratory muscle pumps (18).  Recent work 245 
has demonstrated a close correlation between thigh cross-sectional area and relative VO2peak in 246 
Fontan patients (20).  It is unclear whether impaired cardiac function in Fontan patients 247 
contributes to an under-muscled phenotype, e.g. by impaired nutritive flow and slower 248 
oxygenation kinetics during development (21).  Nevertheless, it is clear that the muscle strength 249 
responds well to exercise training in Fontan patients (in both respiratory and ambulatory 250 
muscles) (22), suggesting that physical activity and exercise training are an important target to 251 
help maintain physical function and aerobic capacity.  This is further supported by self-reported 252 
active lifestyle being independently associated with VO2peak on multivariable analysis. 253 
While describing the exercise adaptation patterns of HCF patients is important in 254 
understanding the physiology during exercise in these patients, we also attempted to determine 255 
risk factors earlier in life that could explain why certain Fontan patients were able to have more 256 
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normal exercise capacity.  While there were no differences between anatomic or surgical 257 
phenotype, we found significant differences between the groups in length of stay following 258 
Fontan completion, post-Fontan complications and body mass index at hospital discharge.  259 
Additionally, there was a statistically significant correlation between VO2peak and post-Fontan 260 
complications and length of stay following Fontan.  This can imply that a difficult postoperative 261 
course following the Fontan negatively affects future functional capacity.  This is in keeping 262 
with previous research demonstrating length of stay as a strong risk factor for worse late 263 
outcomes (23).  While length of stay was not shown to be associated with VO2peak on 264 
multivariable analysis, this may be a reflection of the overall small numbers in this study.  265 
Ventricular systolic function at the time of CPET appears to be associated with functional 266 
capacity.  For one, systolic dysfunction was less common in the HCF compared to the UF group.  267 
When further stratified, the UF patients with worse systolic function had a significantly lower 268 
heart rate response and lower VO2peak, compared to those UF patients with normal systolic 269 
function.  On multivariable analysis, ventricular systolic function at the time of exercise testing 270 
was associated with VO2peak.  This is the opposite of previously reported findings, yet this is a 271 
somewhat intuitive finding which stresses the importance of a healthy myocardium in achieving 272 
a high aerobic capacity (24). 273 
We found no significant differences in GGT between the HCF and UF groups.  GGT is 274 
one of the earliest markers of Fontan associated liver disease and increases primarily in response 275 
to congestion (25).  Our findings suggest that the physically active and aerobically fit HCF 276 
patients had no greater degree of systemic congestion than UF.  This is reassuring in that it 277 
suggests the physiologic adaptation required for greater physical activity and physical fitness 278 
does not necessarily increase the burden of hepatic disease as we and others have previously 279 
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suggested (26-27).  Indeed, the tendency for a lower incidence of liver abnormality in the HCF 280 
group is consistent with the protective effect of aerobic fitness and/or activity on liver and 281 
inflammatory function, as demonstrated in preclinical studies (28).  This study therefore has 282 
important implications in highlighting the potential positive role that exercise rehabilitation 283 
geared towards skeletal muscle strength improvement may play in cardiovascular functioning 284 
during submaximal exercise in Fontan patients.  285 
There were several limitations to this study.  This was a retrospective observational study 286 
over an extended period of time.  The active study group was composed of only 22 patients, 287 
which is a relatively small number and limited the sensitivity to detect significant differences 288 
among variables between the groups.  In addition, activity was self-reported by patients and 289 
noted in chart review, which while helpful in showing the health perception of Fontan patients is 290 
not as effective as objective measures of daily physical activity such as activity monitors.  291 
Addition study using validated surveys and activity monitors should be performed examining the 292 
exercise habits of Fontan patients.  We did not directly measure stroke volume or cardiac output 293 
during exercise, and we did not specifically investigate arterio-venous O2 concentration 294 
differences to identify the role of skeletal muscle O2 extraction.  In this study we also did not 295 
endeavor to define differences between the Fontan circulation and normal subjects during 296 
submaximal exercise, and we refer the reader to previous studies for that comparison (18-19).  297 
Lastly, the determination of ventilatory anaerobic threshold by V-slope is subjective with 298 
significant reviewer variability and its clinical use may be limited for these reasons (29).    299 
In conclusion, almost one fifth of Fontan patients can achieve a normal aerobic capacity 300 
on a cardiopulmonary exercise test.  These HCF patients tended to have a shorter, less 301 
complicated immediate postoperative course, implying that difficulties during the post-Fontan 302 
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period have long-lasting, detrimental effects on cardiorespiratory fitness.  These patients also 303 
tend to have normal ventricular systolic function, highlighting the importance of myocardial 304 
health in maximizing aerobic capacity. In addition, we observed a significantly greater O2Pulse 305 
during submaximal exercise in HCF patients suggesting better preserved SV in this high capacity 306 
group.  Finally, HCF patients self-reported greater habitual physical activity, which may be due 307 
to better exercise tolerance or, more intriguingly, it may be that regular exercise training 308 
increases cardiorespiratory fitness, as demonstrated in Fontan rehabilitation studies.  Overall, 309 
these data imply that stronger skeletal and respiratory muscle pump function may increase pre-310 
load and SV, allowing normal aerobic capacity in these patients.  These findings highlight the 311 
importance of preserving the mechanisms that allows for stroke volume augmentation 312 
throughout the Fontan patient’s lifetime.  313 
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FIGURE LEGENDS: 408 
Figure 1: A comparison of the VO2, heart rate, O2Pulse, and VE/VCO2 slope between the high 409 
capacity (orange) and usual (purple) Fontan patients during incremental exercise.  HCF (high 410 
capacity Fontan), UF (usual Fontan), VO2 (oxygen uptake), % Pred (percent predicted), O2Pulse 411 
(oxygen pulse), VE/VCO2 (ventilatory equivalent for CO2 output), AT (anaerobic threshold).  412 
 413 
Figure 2: Parallel plot demonstrating the progression of percent predicted of VO2peak during 414 
different stages of exercise in individual patients.  415 
 416 
Figure 3: Differences at peak exercise between VO2, O2Pulse, and heart rate between the high 417 
capacity Fontans (orange), usual Fontan with normal systolic function (purple) and usual Fontans 418 
with abnormal systolic function (blue).  VO2 (oxygen uptake), O2Pulse (oxygen pulse), AT 419 




 HCF  UF p-value 
Number (n) 22 88  
Female Sex (%) 68% 45% 0.06 
Age at CPET (yrs) 18.1±6.6 17.3±6.0 0.60 
Age at Fontan (yrs) 3.6±1.6 4.0±1.8 0.46 
Time from Fontan 
completion to CPET 
(yrs) 
14.7±6.7 13.6±6 0.49 
Height (cm) 159±15 162±10 0.50 
Weight (kg) 53.2±18.4 60.7±18.6 0.13 
BSA (m2) 1.52±0.30 1.64±0.30 0.26 
Anatomic diagnosis 
Tricuspid atresia 54%  
HLHS 14% 






Tricuspid atresia 39% 
HLHS 32% 

















 NA 5% NA 4% 
Systemic LV  77% 63% 0.19 
Predominant rhythm 
Sinus 84% 
Ectopic atrial 16% 
Sinus 96% 










Active lifestyle 77% 10% <0.00001 
Cardiac medication 





















Fontan LOS (days) 8.1±2.8 12.4±8.9 0.04 
Pre-Fontan SpO2 (%) 80.9±4.3 81.4±4.1 0.40 
Post-operative 
complications (%) 
8% 36% 0.04 
Cardiopulmonary 
bypass time (min) 
91.8±17.5 99.8±30.9 0.20 
Time from Glenn to 
Fontan (yrs) 
3.1±1.5 3.2±1.8 0.50 
Height at hospital 
discharge (cm) 
97.9±12.1 97.7±10.7 0.90 
Weight at hospital 
discharge (kg) 
13.9±3.6 15.3±5.3 0.30 
BMI at hospital 
discharge (kg/m2) 
14.5±1.3 15.9±2.1 0.01 
 
Table 1: Baseline demographics and clinical characteristics of HCF and UF patients at time of 
exercise test.  HCF (high capacity Fontan), UF (usual Fontan), CPET (cardiopulmonary exercise 
test), yrs (years), BSA (body surface area), cm (centimeters), kg (kilograms), m2 (meters 
squared), BMI (body mass index), LV (left ventricle), HLHS (hypoplastic left heart syndrome), 
PA (pulmonary atresia), IVS (intact ventricular septum), DORV (double outlet right ventricle), 
TGA (transposition of the great arteries), CAVC (complete atrioventricular canal defect), EC 
(extracardiac), LT (lateral tunnel), AP (atriopulmonary), NA (unknown), NYHA (New York 














Echocardiogram results        
    Abnormal ventricular function 1 (mild) /21 
15 (mild), 5 
(mod), 1 (sev) 
/81  0.03 
    Mod-sev AV valve insufficiency 2 /21 12 /80  0.52 
PFT results       
    FVC (% pred)  77.1±15 /19 79.3±15.4 /76 >80 0.59 
    FEV1 (% pred) 76.4±15.6 /19 77.1±17.3 /76 >80 0.87 
    FEV1/FVC (% pred) 99.9±7.1 /19 96.5±9.8 /76 >80 0.19 
    Breathing reserve (%) 39.7±10.6 /19 44.8±16.3 /76 >20 0.20 
Laboratory results       
    Hemoglobin (gm/dL) 16±1.4 /19 15.5±1.6 /65 13-16 0.21 




    Albumin (gm/dL) 4.4±0.4 /19 4.2±0.6 /64 3.3-4.8 0.22 
    AST (u/L) 27.2±21.1 /19 27.4±10.7  /69 10-36 0.10 
    ALT (u/L) 36.9±25.4 /19 39±18 /69 12-49 0.28 
    Total Protein (mg/dL) 7.5±1.1 /19 7.5±1.4 /62 0.1-11 0.75 
    GGT (u/L) 62.4±39.7 /16 84.4±55.3 /31 5-55 0.06 
 
Table 2: Resting echocardiographic, spirometric and laboratory results in HCF and UF patients. 
HCF (high capacity Fontan), UF (usual Fontan), n (number), Mod (moderate), sev (severe), AV 
Table 2
(atrioventricular), FVC (forced vital capacity), FEV1 (forced expiratory volume in 1 second), % 
pred (percent predicted), AST (aspartate aminotransferase), ALT (alanine aminotransferase), 
GGT (gamma-glutamyl transferase). 
 
 25% peak power Anaerobic threshold 
 HCF UF p-value HCF UF p-value 
HR (min-1) 95.7±14.1 103.3±14.5 0.03 138±21 134.5±23.7 0.410 
HR (% pred peak) 47.4±6.9 50.9±6.6 0.03 68.3±10 66.3±11 0.350 
SBP (mm Hg) 126.8±16.8 130±13.7 0.19 145±23.7 143.7±17.8 0.930 
VO2 (% pred of 
VO2peak) 
34.3±10.5 26.7±5.9 <0.0001 61.8±9.6 46.8±12 <0.0001 
Indexed VO2 
(ml.kg.min-1) 
12.1±3.1 10.5±2.3 0.006 21.9±18.6 18.6±0.6 0.008 
O2Pulse (% pred of 
maximum O2Pulse) 
71.3±16.2 53.4±13.5 <0.0001 91.6±16.2 71±16.9 <0.0001 
Power output (% 
pred of peak power) 
31.5±10.5 29.2±10.2 0.35 65.5±15.9 42.1±17.8 <0.0001 
VE (L.min
-1) 17.3±4.0 18.5±4.3 0.23 34.0±7.6 33.2±9.2 0.630 
RR (min-1) 28.5±11 28.6±7.3 0.43 35.9±11.5 36.6±11 0.780 
VT (L) 7.8±2.8 8.4±2.9 0.48 12.8±5.1 11.8±4.4 0.450 
SpO2 (%) 95.6±2.7 93.6±4 0.03 94.5±4.8 92.7±4.2 0.020 
VE/VCO2  36.1±6.2 35.3±6.1 0.45 30±5.8 32.5±7.9 0.090 
 
Table 3: Submaximal cardiopulmonary exercise test responses between the high capacity Fontan 
(HCF) and usual Fontan (UF) patients at 25% peak power and anaerobic threshold. HCF (high 
capacity Fontan), UF (usual Fontan), RER (respiratory exchange ratio), VO2 (oxygen uptake), % 
pred (percent predicted), O2Pulse (oxygen pulse), VE (minute ventilation), RR (respiratory rate), 
Table 3
SpO2 (oxygen saturation by pulse oximetry), SBP (systolic blood pressure), HR (heart rate), VT 
















min 8.7±1.1 8.1±1.4 8-10 0.060 
Peak power (% 
pred) 
% 93.1±12.8 66.9±17.9 >80 <0.0001 
VO2peak (% pred) % 86.1±6.1 61.5±12.2 >80 <0.0001 
VO2peak ml.kg.min
-1 30.6±4.8 24.2±5.8 Variable <0.0001 
Peak O2Pulse (% 
pred) 
% 103.9±9.2 76.8±18.2 >80 <0.0001 
Baseline SpO2  % 97.6±1.8 96.0±2.2 >90 0.001 
Peak SpO2  % 94.9±2.7 93.4±4.1 >90 0.130 
SBP  mm Hg 154.1±25.9 157.3±20.2 Variable 0.540 
Peak HR min-1 168.1±13.9 165.4±25 Variable 0.780 
Peak HR (% pred) % 83.3±6.5 81.5±11.6 >85 0.880 
Chronotropic index % 74.3±9.0 69.8±19.1 >80 0.610 
FVE/FVCO2  32.1±4.4 34.9±7.3 Variable 0.100 
Peak VE  L.min
-1 59.9±20.2 57.6±20.9 Variable 0.630 
Peak RR  min-1 48.6±8.9 49.4±11.6 <60 0.750 
 
Table 4
Table 4: Cardiopulmonary exercise test responses between the high capacity Fontan (HCF) and 
usual Fontan (UF) patients at peak exercise. HCF (high capacity Fontan), UF (usual Fontan), 
RER (respiratory exchange ratio), VO2 (oxygen uptake), % pred (percent predicted), O2Pulse 
(oxygen pulse), SpO2 (oxygen saturation by pulse oximetry), SBP (systolic blood pressure), HR 




Univariate analysis R value P value 
    Active lifestyle  0.45 <0.0001 
    Pre-CPET systolic function 0.29 0.004 
    Post-operative complications -0.25 0.030 
    BMI at hospital discharge  -0.25 0.030 
    Fontan LOS  -0.22 0.040 
    Cardiopulmonary bypass time -0.16 0.190 
    Weight at hospital discharge -0.13 0.300 
    Age at CPET -0.05 0.600 
    Time from Glenn to Fontan -0.01 0.900 
    Height at hospital discharge 0.003 0.900 
Multivariable analysis Standardized く coefficient 
(parameter estimates) 
P value 
    Active lifestyle 0.24 (9.5±4.6) 0.040 
    Pre-CPET systolic function -0.20 (-7.4±3.6) 0.040 
    BMI at hospital discharge -0.20 (-1.7±0.9) 0.070 
    Post-operative complications -0.03 (-1.1±4.9) 0.800 
    Fontan LOS -0.02 (-0.03±0.2) 0.900 
Table 5: Results of the univariate and multivariable analysis for percent predicted of VO2peak. 
VO2 (oxygen uptake), CPET (cardiopulmonary exercise test), BMI (body mass index), LOS 
(length of stay). 
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